Literature DB >> 7049133

Duration of effect of pilocarpine gel.

W F March, R M Stewart, A I Mandell, L A Bruce.   

Abstract

Thirty-five patients participated in a clinical trial of pilocarpine hydrochloride gel applied once daily at 10 PM. Patients tolerated the medication well and there were no untoward side effects. Significant lowering of intraocular pressure was found for 24 hours after administration. The effect 12 hours after administration was greater than 24 hours after administration. Therefore, pilocarpine gel can be endorsed as an effective medication for 24 hours in the vast majority of patients. However, it is incumbent on the prescribing ophthalmologist to measure the IOP at 10 PM at least once after prescribing pilocarpine gel to ensure adequate control of IOP at that time.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049133     DOI: 10.1001/archopht.1982.01030040248007

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Efficacy and safety of the combination therapy Pilogel/beta-blocker: interim results.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Doc Ophthalmol       Date:  1989-08       Impact factor: 2.379

2.  Long-term treatment with Pilogel/beta-blocker in glaucoma patients.

Authors:  S Maas; F E Ros; L J De Heer; R J De Keizer
Journal:  Int Ophthalmol       Date:  1991-07       Impact factor: 2.031

3.  Long-term effects of glaucoma therapy with 4% pilocarpine gel on corneal clarity and endothelial cell density.

Authors:  S Nagasubramanian; R H Stewart; R A Hitchings
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

4.  Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop.

Authors:  P Suhonen; T Järvinen; K Lehmussaari; T Reunamäki; A Urtti
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study.

Authors:  F P Gunning; E L Greve; A M Bron; J M Bosc; J G Royer; J L George; P Lesure; D Sirbat
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1993-07       Impact factor: 3.117

6.  Prolonged pulse-entry of pilocarpine with a soluble drug insert.

Authors:  L Salminen; A Urtti; H Kujari; M Juslin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.